SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-22-001691
Filing Date
2022-03-29
Accepted
2022-03-29 16:08:08
Documents
17
Period of Report
2022-03-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vnrx_8k.htm   iXBRL 8-K 31674
2 PRESS RELEASE vnrx_ex991.htm EX-99.1 27565
8 vnrx_ex99img1.jpg GRAPHIC 2024
9 vnrx_ex99img2.jpg GRAPHIC 1866
  Complete submission text file 0001477932-22-001691.txt   193106

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20220328.xsd EX-101.SCH 5830
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20220328_lab.xml EX-101.LAB 15320
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20220328_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20220328_pre.xml EX-101.PRE 9743
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20220328_def.xml EX-101.DEF 2103
11 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_8k_htm.xml XML 3727
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 22780845
SIC: 2835 In Vitro & In Vivo Diagnostic Substances